Small molecule · developed by Xenon Pharmaceuticals
XPF-010 is a capsule formulation of XEN1101 in a trial conducted in healthy volunteers.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT03340220 | Phase 1 | Healthy Volunteers | Completed | XENE |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Healthy Volunteers
Updated Nov 1, 2026. Something wrong or missing? Report it on the XENE page.
See XENE's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
XENE catalysts and pipeline →